RBM48
gene geneOn this page
Also known as DKFZp564O0523HSPC304
Summary
RBM48 (RNA binding motif protein 48, HGNC:21785) is a protein-coding gene on chromosome 7q21.2, encoding RNA-binding protein 48 (Q5RL73). As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs. It is a common-essential gene (DepMap: required in 91.7% of cancer cell lines).
Predicted to enable RNA binding activity. Predicted to be involved in RNA splicing and mRNA processing. Located in nucleoplasm.
Source: NCBI Gene 84060 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 87 total — 1 likely-pathogenic
- Phenotypes (HPO): 1
- Cancer dependency (DepMap): dependent in 91.7% of screened cell lines (common-essential)
- MANE Select transcript:
NM_032120
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21785 |
| Approved symbol | RBM48 |
| Name | RNA binding motif protein 48 |
| Location | 7q21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZp564O0523, HSPC304 |
| Ensembl gene | ENSG00000127993 |
| Ensembl biotype | protein_coding |
| OMIM | 621015 |
| Entrez | 84060 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000265732, ENST00000481551, ENST00000496410
RefSeq mRNA: 3 — MANE Select: NM_032120
NM_001363366, NM_001363367, NM_032120
CCDS: CCDS43615
Canonical transcript exons
ENST00000265732 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001280081 | 92532404 | 92532549 |
| ENSE00001294734 | 92536851 | 92540481 |
| ENSE00002462390 | 92534402 | 92534970 |
| ENSE00003525278 | 92529476 | 92529666 |
| ENSE00003841329 | 92528795 | 92528924 |
Expression profiles
Bgee: expression breadth ubiquitous, 264 present calls, max score 91.40.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 15.9474 / max 1485.4198, expressed in 1770 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 79528 | 15.9474 | 1770 |
Top tissues by expression
282 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 91.40 | gold quality |
| secondary oocyte | CL:0000655 | 90.88 | gold quality |
| oocyte | CL:0000023 | 87.11 | gold quality |
| medial globus pallidus | UBERON:0002477 | 86.02 | gold quality |
| globus pallidus | UBERON:0001875 | 83.26 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.12 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 82.63 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 81.52 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 81.47 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 80.49 | gold quality |
| corpus callosum | UBERON:0002336 | 80.27 | gold quality |
| right frontal lobe | UBERON:0002810 | 80.23 | gold quality |
| bone marrow | UBERON:0002371 | 80.11 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 80.02 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 79.74 | gold quality |
| gastrocnemius | UBERON:0001388 | 79.68 | gold quality |
| muscle of leg | UBERON:0001383 | 79.45 | gold quality |
| spinal cord | UBERON:0002240 | 79.45 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 79.44 | gold quality |
| cerebellar cortex | UBERON:0002129 | 79.43 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 79.34 | gold quality |
| monocyte | CL:0000576 | 79.27 | gold quality |
| tendon | UBERON:0000043 | 79.26 | gold quality |
| leukocyte | CL:0000738 | 79.21 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 79.17 | gold quality |
| mononuclear cell | CL:0000842 | 79.00 | gold quality |
| granulocyte | CL:0000094 | 78.90 | gold quality |
| lower lobe of lung | UBERON:0008949 | 78.89 | gold quality |
| cerebellum | UBERON:0002037 | 78.86 | gold quality |
| jejunal mucosa | UBERON:0000399 | 78.42 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.62 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
104 targeting RBM48, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-6851-5P | 100.00 | 65.63 | 1294 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-3689D | 100.00 | 66.14 | 1181 |
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-1184 | 99.99 | 68.19 | 1458 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-433-3P | 99.98 | 69.37 | 1203 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-218-5P | 99.93 | 72.22 | 2103 |
| HSA-MIR-205-3P | 99.92 | 69.92 | 3165 |
| HSA-MIR-5680 | 99.91 | 69.83 | 3421 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-129-5P | 99.88 | 70.26 | 3273 |
| HSA-MIR-221-5P | 99.86 | 65.45 | 1052 |
| HSA-MIR-8073 | 99.86 | 65.21 | 1118 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 91.7% of screened cell lines, common-essential.
Literature-anchored findings (GeneRIF, showing 1)
- Genetic analysis of human RNA binding motif protein 48 (RBM48) reveals an essential role in U12-type intron splicing. (PMID:36040194)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | rbm48 | ENSDARG00000033754 |
| mus_musculus | Rbm48 | ENSMUSG00000040302 |
| rattus_norvegicus | Rbm48 | ENSRNOG00000008980 |
| drosophila_melanogaster | CG34231 | FBGN0085260 |
Protein
Protein identifiers
RNA-binding protein 48 — Q5RL73 (reviewed: Q5RL73)
All UniProt accessions (2): Q5RL73, C9J787
UniProt curated annotations — full annotation on UniProt →
Function. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs.
Subunit / interactions. Component of the minor spliceosome. Within this complex, interacts with ARMC7 and PRPF8/PRP8.
Similarity. Belongs to the RBM48 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5RL73-1 | 1 | yes |
| Q5RL73-2 | 2 |
RefSeq proteins (3): NP_001350295, NP_001350296, NP_115496* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR034264 | RBM48_RRM | Domain |
| IPR035979 | RBD_domain_sf | Homologous_superfamily |
| IPR039599 | RBM48 | Family |
UniProt features (20 total): strand 5, helix 3, region of interest 3, sequence conflict 3, turn 2, chain 1, domain 1, compositionally biased region 1, splice variant 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7DVQ | ELECTRON MICROSCOPY | 2.89 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5RL73-F1 | 68.68 | 0.30 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 106 (showing top):
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN, WTGAAAT_UNKNOWN, GOBP_RNA_SPLICING, CDPCR3HD_01, PARENT_MTOR_SIGNALING_UP, TGGAAA_NFAT_Q4_01, GOCC_CATALYTIC_STEP_2_SPLICEOSOME, GOCC_SPLICEOSOMAL_COMPLEX, GOCC_RIBONUCLEOPROTEIN_COMPLEX, GOCC_U12_TYPE_SPLICEOSOMAL_COMPLEX, WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D, GOBP_MRNA_PROCESSING, SHEN_SMARCA2_TARGETS_UP, ASH1L_TARGET_GENES, CEBPZ_TARGET_GENES
GO Biological Process (2): mRNA processing (GO:0006397), RNA splicing (GO:0008380)
GO Molecular Function (3): RNA binding (GO:0003723), nucleic acid binding (GO:0003676), protein binding (GO:0005515)
GO Cellular Component (2): nucleoplasm (GO:0005654), spliceosomal complex (GO:0005681)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA processing | 2 |
| binding | 2 |
| mRNA metabolic process | 1 |
| nucleic acid binding | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
| nuclear protein-containing complex | 1 |
| ribonucleoprotein complex | 1 |
Protein interactions and networks
STRING
1612 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RBM48 | ARMC7 | Q9H6L4 | 766 |
| RBM48 | FAM133B | Q5BKY9 | 540 |
| RBM48 | FAM186B | Q8IYM0 | 525 |
| RBM48 | THAP8 | Q8NA92 | 507 |
| RBM48 | GATAD1 | Q8WUU5 | 506 |
| RBM48 | ANKIB1 | Q9P2G1 | 477 |
| RBM48 | HEPACAM2 | A8MVW5 | 438 |
| RBM48 | ZNF483 | Q8TF39 | 398 |
| RBM48 | SCNM1 | Q9BWG6 | 394 |
| RBM48 | FAM168B | A1KXE4 | 371 |
| RBM48 | TMEM243 | Q9BU79 | 370 |
| RBM48 | ZNF713 | Q8N859 | 364 |
| RBM48 | VMA22 | Q96NT0 | 358 |
| RBM48 | THOC3 | Q96J01 | 354 |
| RBM48 | ALKBH6 | Q3KRA9 | 347 |
IntAct
124 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RBM48 | ARMC7 | psi-mi:“MI:0915”(physical association) | 0.800 |
| TEKT4 | RBM48 | psi-mi:“MI:0915”(physical association) | 0.560 |
| S100Z | RBM48 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PIBF1 | RBM48 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBM48 | EIF1AD | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBM48 | TSR2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBM48 | KIF9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC57 | RBM48 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBM48 | ATPAF2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MLH1 | RBM48 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RAD51D | RBM48 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBM48 | NTAQ1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBM48 | TBC1D22B | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBM48 | SPRED2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| COX5B | RBM48 | psi-mi:“MI:0915”(physical association) | 0.560 |
| POLR1C | RBM48 | psi-mi:“MI:0915”(physical association) | 0.560 |
| AMOT | RBM48 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRKAB2 | RBM48 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBM48 | FAM90A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GYS1 | RBM48 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBM48 | JMY | psi-mi:“MI:0915”(physical association) | 0.560 |
| HSF2BP | RBM48 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBM48 | TEKT4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBM48 | SCNM1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBM48 | S100Z | psi-mi:“MI:0915”(physical association) | 0.560 |
| NUDT21 | RBM48 | psi-mi:“MI:0915”(physical association) | 0.550 |
| TK1 | RBM48 | psi-mi:“MI:0915”(physical association) | 0.550 |
| RBM48 | NBEA | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (93): RBM48 (Affinity Capture-MS), ARMC7 (Affinity Capture-MS), ARMC7 (Affinity Capture-Western), RBM48 (Affinity Capture-Western), NBEA (Affinity Capture-MS), ARMC7 (Affinity Capture-MS), RBM48 (Two-hybrid), RBM48 (Two-hybrid), RBM48 (Two-hybrid), RBM48 (Two-hybrid), RBM48 (Two-hybrid), RBM48 (Two-hybrid), RBM48 (Two-hybrid), RBM48 (Two-hybrid), RBM48 (Two-hybrid)
ESM2 similar proteins: A4FVJ7, A6QPE1, E7F7X0, F1Q8J0, O43683, O60566, P92204, Q08AZ1, Q0VBD2, Q32NQ8, Q3MHP0, Q3UZ01, Q4G055, Q4R707, Q561R3, Q5F3D1, Q5HZN1, Q5R4U2, Q5R6C7, Q5R789, Q5RL73, Q5SPR8, Q5ZIX8, Q6DD45, Q6DE94, Q6DJS0, Q6GQJ2, Q6IE81, Q6IRB8, Q6NZY4, Q6P2L6, Q6XV80, Q6ZPI0, Q76FK4, Q7L590, Q7ZVP1, Q7ZXG4, Q801E2, Q8JZV4, Q8K298
Diamond homologs: A4FVJ7, A6QPE1, Q561R3, Q5R4U2, Q5RL73, Q8K2X2
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 75 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Transcriptional Regulation by TP53 | 7 | 9.1× | 4e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| regulation of G1/S transition of mitotic cell cycle | 5 | 22.5× | 1e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
87 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 1 |
| Uncertain significance | 56 |
| Likely benign | 10 |
| Benign | 13 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 548642 | NM_032120.4(RBM48):c.835A>G (p.Thr279Ala) | Likely pathogenic |
SpliceAI
594 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:92529626:G:GT | donor_gain | 1.0000 |
| 7:92532398:A:AG | acceptor_gain | 1.0000 |
| 7:92532399:T:G | acceptor_gain | 1.0000 |
| 7:92532400:TCA:T | acceptor_loss | 1.0000 |
| 7:92532401:CA:C | acceptor_loss | 1.0000 |
| 7:92532402:A:AC | acceptor_loss | 1.0000 |
| 7:92532402:A:AG | acceptor_gain | 1.0000 |
| 7:92532402:AG:A | acceptor_gain | 1.0000 |
| 7:92532403:G:GT | acceptor_gain | 1.0000 |
| 7:92532403:GG:G | acceptor_gain | 1.0000 |
| 7:92532403:GGAC:G | acceptor_gain | 1.0000 |
| 7:92532403:GGACA:G | acceptor_gain | 1.0000 |
| 7:92532515:G:GT | donor_gain | 1.0000 |
| 7:92532519:GCA:G | donor_gain | 1.0000 |
| 7:92532526:T:TA | donor_gain | 1.0000 |
| 7:92532527:A:AA | donor_gain | 1.0000 |
| 7:92536549:G:GG | donor_gain | 1.0000 |
| 7:92536847:TTA:T | acceptor_loss | 1.0000 |
| 7:92536848:TAG:T | acceptor_loss | 1.0000 |
| 7:92536850:G:GA | acceptor_loss | 1.0000 |
| 7:92536850:GGTA:G | acceptor_gain | 1.0000 |
| 7:92529470:TTTCA:T | acceptor_loss | 0.9900 |
| 7:92529471:TTCAG:T | acceptor_loss | 0.9900 |
| 7:92529473:CA:C | acceptor_loss | 0.9900 |
| 7:92529474:A:AT | acceptor_loss | 0.9900 |
| 7:92529475:GGTAT:G | acceptor_gain | 0.9900 |
| 7:92529663:CAAGG:C | donor_loss | 0.9900 |
| 7:92529666:GGT:G | donor_loss | 0.9900 |
| 7:92529667:G:C | donor_loss | 0.9900 |
| 7:92529668:T:G | donor_loss | 0.9900 |
AlphaMissense
2408 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:92532413:G:C | K104N | 0.998 |
| 7:92532413:G:T | K104N | 0.998 |
| 7:92529636:T:C | L91P | 0.997 |
| 7:92529498:C:T | S45F | 0.996 |
| 7:92529620:T:C | F86L | 0.996 |
| 7:92529622:T:A | F86L | 0.996 |
| 7:92529622:T:G | F86L | 0.996 |
| 7:92532409:C:A | A103D | 0.996 |
| 7:92529497:T:C | S45P | 0.995 |
| 7:92529513:T:A | I50K | 0.995 |
| 7:92529645:T:C | F94S | 0.995 |
| 7:92532466:C:A | A122D | 0.995 |
| 7:92529632:T:G | Y90D | 0.994 |
| 7:92529507:T:C | L48S | 0.993 |
| 7:92529522:T:A | V53D | 0.993 |
| 7:92529644:T:C | F94L | 0.993 |
| 7:92529646:T:A | F94L | 0.993 |
| 7:92529646:T:G | F94L | 0.993 |
| 7:92532457:T:A | V119E | 0.993 |
| 7:92529503:T:G | Y47D | 0.992 |
| 7:92529513:T:G | I50R | 0.992 |
| 7:92532451:T:A | L117H | 0.992 |
| 7:92528892:T:C | Y27H | 0.991 |
| 7:92529639:T:A | I92N | 0.991 |
| 7:92532404:G:C | R101S | 0.991 |
| 7:92532404:G:T | R101S | 0.991 |
| 7:92532435:T:C | F112L | 0.991 |
| 7:92532437:C:A | F112L | 0.991 |
| 7:92532437:C:G | F112L | 0.991 |
| 7:92532453:C:G | H118D | 0.991 |
dbSNP variants (sampled 300 via entrez): RS1000014747 (7:92537605 A>G), RS1000317139 (7:92539844 C>G), RS1000490837 (7:92537842 T>A), RS1000791010 (7:92529341 T>G), RS1000885834 (7:92529557 C>A,G), RS1000961060 (7:92533786 A>G), RS1001016310 (7:92533989 AC>A), RS1001035485 (7:92540156 A>G), RS1001092109 (7:92539128 A>T), RS1001231526 (7:92534341 G>A), RS1001240192 (7:92527023 G>C,T), RS1001461533 (7:92538823 C>G), RS1003017067 (7:92530933 C>G,T), RS1003074677 (7:92539712 C>T), RS1003129252 (7:92537747 C>G,T)
Disease associations
OMIM: gene MIM:621015 | disease phenotypes: MIM:256100
GenCC curated gene-disease
Mondo (1): nephronophthisis (MONDO:0019005)
Orphanet (1): Nephronophthisis (Orphanet:655)
HPO phenotypes
1 total (1 of 1 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000090 | Nephronophthisis |
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005588_34 | Idiopathic dilated cardiomyopathy | 7.000000e-06 |
| GCST012227_124 | Hip circumference adjusted for BMI | 1.000000e-10 |
| GCST90020028_173 | Hip circumference adjusted for BMI | 2.000000e-10 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009094 | idiopathic dilated cardiomyopathy |
| EFO:0008039 | BMI-adjusted hip circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
30 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases abundance, increases expression | 3 |
| Air Pollutants | affects expression, increases abundance, decreases expression | 2 |
| Formaldehyde | decreases expression, increases expression | 2 |
| Tobacco Smoke Pollution | increases expression | 2 |
| Valproic Acid | affects expression, decreases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| propionaldehyde | decreases expression | 1 |
| lei gong teng | increases expression | 1 |
| epigallocatechin gallate | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| cylindrospermopsin | increases expression | 1 |
| abrine | increases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| MT19c compound | increases expression | 1 |
| Leflunomide | increases expression | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Cisplatin | decreases expression, affects cotreatment | 1 |
| Coal | increases abundance, decreases expression | 1 |
| Copper | affects binding, decreases expression | 1 |
| Disulfiram | decreases expression, affects binding | 1 |
| Folic Acid | decreases expression | 1 |
| Hydrogen Peroxide | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Phenylmercuric Acetate | decreases expression | 1 |
| Smoke | decreases expression, increases abundance | 1 |
| Urethane | affects expression | 1 |
| Acrylamide | increases expression | 1 |
| Particulate Matter | increases expression | 1 |
Clinical trials (associated diseases)
6 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT01022957 | Not specified | COMPLETED | Nephronophthisis : Clinical and Genetic Study |
| NCT01401998 | Not specified | RECRUITING | ARPKD Database Study |
| NCT04874909 | Not specified | COMPLETED | Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) |
| NCT05286632 | Not specified | COMPLETED | KidneYou - Innovative Digital Therapy |
| NCT06065852 | Not specified | RECRUITING | National Registry of Rare Kidney Diseases |
| NCT06648044 | Not specified | RECRUITING | Research of Therapeutic Targets in the Frame of Nephronophthisis and Renal Associated Ciliopathies |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): nephronophthisis